Squamous Cell Carcinoma
Squamous Cell Carcinoma (SCC) of the Skin and Head and Neck
Clinical trials are currently being conducted to evaluate the treatment of Squamous Cell Carcinoma of the Head and Neck, and Skin using Alpha DaRT. The treatment is conducted under local anesthesia in a regular procedure room. No special shielding or equipment is required.
Each patient is treated under local anesthesia in a single short session. The treatment is delivered by inserting Alpha DaRT seeds into to the tumor. Using ultra-minimally invasive applicators minimizes patient discomfort and improves the aesthetic outcome of the procedure. The Alpha DaRT seeds are stringed on a suture which enables the seeds’ removal according to the doctor's decision and evaluation of necessity.
In most cases, the patient is released from the clinic immediately after the procedure. Follow-up examinations are conducted throughout the trial to ensure the patient’s safety and to record necessary data.
Ongoing Clinical Trials
Treatment of Squamous Cell Carcinoma (SCC) is currently running at: